StockData
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Inc (LBRX) stock

LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.30−2.69 (-6.26%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

LB Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

LB Pharmaceuticals's price to book ratio was 3.9× on Nov 11, 2026, against 1.5× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.9×+2.0
2025Dec 31, 20251.8×–

More LB Pharmaceuticals figures

See a number that looks wrong?